KRAS and enteropathy-associated T-cell lymphoma: We furthermore observed frequent alterations in the MAPK pathway in 80% of EATL-II cases, including TP53 (33%), BRAF (26%), KRAS (20%) and NRAS mutations which were essentially mutually exclusive.